Professor, Surgery, Case Western Reserve University School of Medicine
Urology
Dr. Daniel A. Shoskes, MD
|
|
Give Review
Daniel Shoskes is an expert in the field of Urology. He received awards:"CMS Meaningful Use Stage 1 Certification", "Best Poster Presentation", "Resident Development Award", "Innovator Award", "AST Poster of Distinction Award", "Awarded Best Paper in Society Resident Competition", "First Prize, Resident Essay Competition", "Award for Best Abstract", "Gallie-Bateman Award" and "Young Investigator Award". Daniel Shoskes is a published doctor. He has 101 publications published. The most current publication "Effect of delayed graft function on short- and long-term kidney graft survival." He accepts Medicare payments and is listed with Medicare.gov.
Publications
- Chronic prostatitis/Chronic pelvic pain syndrome: a review of evaluation and therapy.
- 'Spousal Revenge Syndrome'- description of a new Chronic pelvic pain syndrome patient cohort.
- Phenotype, symptom severity and treatment in a 'cured' cohort of Chronic pelvic pain syndrome patients.
- Psychosocial mechanisms of the pain and quality of life relationship for Chronic prostatitis/Chronic pelvic pain syndrome (CP/CPPS).
- Low Testosterone at Time of Transplantation is Independently Associated with Poor Patient and Graft Survival in Male Renal Transplant Recipients.
- An online UPOINT tool for phenotyping patients with Chronic prostatitis.
- Clinical phenotyping of urologic pain patients.
- Contrasting patterns of viral load response in transplant recipients with BK polyomaVirus DNAemia on leflunomide therapy.
- Sexual dysfunction in Chronic prostatitis/Chronic pelvic pain syndrome.
- Classification and treatment of men with Chronic prostatitis/Chronic pelvic pain syndrome using the UPOINT system.
- Lack of predictive correlation between peripheral arterial tone and colour flow Doppler parameters in men with Erectile dysfunction.
- Clustering of UPOINT Domains and Subdomains in Men with Chronic Prostatitis/Chronic Pelvic Pain Syndrome and Contribution to Symptom Severity.
- Androgen deficiency in older men: indications, advantages, and pitfalls of testosterone replacement therapy.
- Greater endothelial dysfunction and arterial stiffness in men with Chronic prostatitis/Chronic pelvic pain syndrome-a possible link to cardiovascular disease.
- Quercetin for Chronic prostatitis/Chronic pelvic pain syndrome.
- Inclusion of Erectile Domain to UPOINT Phenotype Does Not Improve Correlation With Symptom Severity in Men With Chronic Prostatitis/Chronic Pelvic Pain Syndrome.
- The relative risk of overall graft loss and acute rejection among African American Renal transplant recipients is attenuated with advancing age.
- Prevalence and impact of bacteriuria and/or urinary tract infection in interstitial cystitis/painful Bladder syndrome.
- Chronic prostatitis/Chronic pelvic pain syndrome and pelvic floor spasm: can we diagnose and treat?
- Phenotypically directed multimodal therapy for Chronic prostatitis/Chronic pelvic pain syndrome: a prospective study using UPOINT.
- Demographic and clinical characteristics associated with glomerular filtration rates in living Kidney donors.
- Clinical phenotyping of patients with Chronic prostatitis/Chronic pelvic pain syndrome and correlation with symptom severity.
- Incidence and significance of prostatic stones in men with Chronic prostatitis/Chronic pelvic pain syndrome.
- New therapies in Chronic prostatitis.
- Combination treatment with curcumin and quercetin of adenomas in familial adenomatous polyposis.
- GenitoUrinary malignancies in solid organ transplant recipients.
- Multimodal therapy for Chronic prostatitis/Chronic pelvic pain syndrome.
- Anti-nanobacterial therapy for men with Chronic prostatitis/Chronic pelvic pain syndrome and prostatic stones: preliminary experience.
- Treatment response to conventional and novel therapies in Chronic prostatitis.
- Long-term results of multimodal therapy for Chronic prostatitis/Chronic pelvic pain syndrome.
- Phytotherapy in Chronic prostatitis.
- Phytotherapy and other alternative forms of care for the patient with prostatitis.
- Cytokine polymorphisms in men with Chronic prostatitis/Chronic pelvic pain syndrome: association with diagnosis and treatment response.
- Quercetin in men with category III Chronic prostatitis: a preliminary prospective, double-blind, placebo-controlled trial.
- The effect of mycophenolate mofetil and polyphenolic bioflavonoids on Renal ischemia reperfusion injury and repair.
- Resolution of the Chronic pelvic pain syndrome after renal transplantation.
- The role of urology in transplantation and of transplantation in urology.
- Nonimmunologic Renal allograft injury and delayed graft function: clinical strategies for prevention and treatment.
- Synergy of mycophenolate mofetil and bioflavonoids in prevention of immune and ischemic injury.
- Oxidant stress in cadaveric and living Kidney donors as markers of renal injury: utility of total antioxidant capacity and isoprostane levels in urine.
- Comparison of preservation solution RPS-96 with university of wisconsin solution in rat Renal ischemia-reperfusion injury.
- Modulation of apoptotic and inflammatory genes by bioflavonoids and angiotensin II inhibition in ureteral obstruction.
- Detection of bacterial signal by 16S rRNA polymerase chain reaction in expressed prostatic secretions predicts response to antibiotic therapy in men with Chronic pelvi...
- Oxidative stress in prostatic fluid of patients with Chronic pelvic pain syndrome: correlation with gram positive bacterial growth and treatment response.
- Oxidant stress and antioxidant capacity in urine of Renal transplant recipients predict early graft function.
- Treatment of interstitial cystitis with a quercetin supplement.
- Use of antibiotics in Chronic prostatitis syndromes.
- Effect of preservation and recipient immune factors on delayed graft function in cadaveric Renal transplantation.
- Down-regulation of apoptotic and inflammatory genes by Cordyceps sinensis extract in rat Kidney following ischemia/reperfusion.
- Quercetin and curcumin up-regulate antioxidant gene expression in rat Kidney after ureteral obstruction or ischemia/reperfusion injury.
- Kidney transplantation at UCLA--the past 10 years.
- Prolonged simple cold storage does not adversely affect Renal allograft outcome in patients receiving cyclosporine.
- The effects of delayed cyclosporine administration in recipients of cadaveric Renal allografts subjected to prolonged cold ischemia.
- Prevalence of corynebacterial 16S rRNA sequences in patients with bacterial and "nonbacterial" prostatitis.
- Prostatitis unplugged? Prostatic massage revisited.
- Induction of specific unresponsiveness using transfected cells expressing donor major histocompatibility complex molecules: evidence for indirect presentation of allop...
- Renal transplantation in patients with Renal cell carcinoma and von Hippel-Lindau disease.
- Warming to non-heart-beating donors?
- Graft outcomes of living donor Renal transplantations in elderly recipients.
- Nutraceuticals in Prostate Disease: The Urologist's Role.
- Alfuzosin and symptoms of Chronic prostatitis-Chronic pelvic pain syndrome.
- Category III Chronic prostatitis/Chronic pelvic pain syndrome: insights from the National Institutes of Health Chronic Prostatitis Collaborative Research Network studies.
- Clinical phenotyping of women with interstitial cystitis/painful Bladder syndrome: a key to classification and potentially improved management.
- Phenotypic approach to the management of Chronic prostatitis/Chronic pelvic pain syndrome.
- Laparo-endoscopic single site (LESS) versus standard laparoscopic left donor nephrectomy: matched-pair comparison.
- The etiology and management of acute prostatitis.
- Pregabalin for the treatment of men with Chronic prostatitis/Chronic pelvic pain syndrome: a randomized controlled trial.
- Phenotypic approach to the management of the Chronic prostatitis/Chronic pelvic pain syndrome.
- Pharmacotherapy of prostatitis.
- Update on urologic pelvic pain syndromes: highlights from the 2010 international Chronic pelvic pain symposium and workshop, august 29, 2010, kingston, ontario, Canada.
- Demographic and clinical characteristics of men with Chronic prostatitis: the national institutes of health Chronic prostatitis cohort study.
- Leukocyte and bacterial counts do not correlate with severity of symptoms in men with Chronic prostatitis: the National Institutes of Health Chronic Prostatitis Cohort...
- Overview summary statement. Diagnosis and management of Chronic prostatitis/Chronic pelvic pain syndrome (CP/CPPS).
- Herbal and complementary medicine in Chronic prostatitis.
- Impact of post-ejaculatory pain in men with category III Chronic prostatitis/Chronic pelvic pain syndrome.
- Ciprofloxacin or tamsulosin in men with Chronic prostatitis/Chronic pelvic pain syndrome: a randomized, double-blind trial.
- Muscle tenderness in men with Chronic prostatitis/Chronic pelvic pain syndrome: the Chronic prostatitis cohort study.
- Emphysematous cystitis: a review of 135 cases.
- Beneficial effects of the bioflavonoids curcumin and quercetin on early function in cadaveric Renal transplantation: a randomized placebo controlled trial.
- The role of nanobacteria in urologic Disease.
- How does the pre-massage and post-massage 2-glass test compare to the Meares-Stamey 4-glass test in men with Chronic prostatitis/Chronic pelvic pain syndrome?
- Current treatment options in the management of Chronic prostatitis.
- Evaluation of alloreactivity in Kidney transplant recipients treated with antithymocyte globulin versus IL-2 receptor blocker.
- Clinical phenotyping in Chronic prostatitis/Chronic pelvic pain syndrome and interstitial cystitis: a management strategy for urologic Chronic pelvic pain syndromes.
- A randomized placebo-controlled multicentre study to evaluate the safety and efficacy of finasteride for male Chronic pelvic pain syndrome (category IIIA Chronic nonba...
- Phase I study of oral bioflavonoids in cadaveric Renal transplant recipients: effects on delayed graft function and calcineurin inhibitor toxicities.
- Correlation of beta-endorphin and prostaglandin E2 levels in prostatic fluid of patients with Chronic prostatitis with diagnosis and treatment response.
- Effective Renal plasma flow calculated from a single blood sample following Technetium-99m mercaptoacetyltriglycine Renal scan can predict delayed graft function in re...
- Delayed graft function. Influence on outcome and strategies for prevention.
- Diagnosis and management of acute and Chronic prostatitis.
- The value of prostate-specific antigen levels in pelvic lymph nodes for diagnosing metastatic spread of prostate Cancer.
- Surgical treatment of renovascular hypertension in moyamoya Disease: case report and review of the literature.
- HLA matching determines susceptibility to harmful effects of delayed graft function in Renal transplant recipients.
- Urological complications in 1,000 consecutive Renal transplant recipients.
- Indirect presentation of MHC antigens in transplantation.
- Effect of delayed graft function on short- and long-term Kidney graft survival.
- Aluminum toxicity and death following intravesical alum irrigation in a patient with Renal impairment.
- Evaluation and treatment of blunt Renal trauma.
- Ischemic injury induces altered MHC gene expression in Kidney by an interferon-gamma-dependent pathway.
- The Urinary Microbiome Differs Significantly between Patients with Chronic Prostatitis/Chronic Pelvic Pain Syndrome and Controls as Well as between Patients with Diffe...
Schools
University Of Toronto Faculty Of Medicine
Procedures Preformed
- Cystometry
- Renal Transplant and Nephrectomy
- TURP (Transurethral Resection of Prostate) or Laser Destruction of Prostate
- Urethral Dilation
- View All
Conditions Treated
- Bladder Cancer
- Chronic Kidney Diseases
- Diverticulum of Bladder
- End-Stage Renal Disease
- View All
Doctors Specialties
- Urology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
- Best Poster Presentation
- Resident Development Award
- Innovator Award
- AST Poster of Distinction Award
- Awarded Best Paper in Society Resident Competition
- First Prize, Resident Essay Competition
- Award for Best Abstract
- Gallie-Bateman Award
- Young Investigator Award
Education
-
University of Toronto Faculty of Medicine
Hospital
-
Cleveland Clinic
Drug Facts
| NPI NUMBER | 1447215587 | |
| NPPES Provider LastName | SHOSKES | |
| NPPES Provider FirstName | DANIEL | |
| NPPES Provider ZIPCode | 441950001 | |
| NPPES Provider State | OH | |
| Specialty Description | Urology | |
| Total Claim Count | 197.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1447215587 |
| Last Name Of The Provider | SHOSKES |
| First Name Of The Provider | DANIEL |
| View All |
Similar Doctors
|
Dr. Edward E. Cherullo, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Howard B. Goldman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jonathan C. Boyd, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Jihad H. Kaouk, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. David A. Goldfarb, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Raj K. Goel, MD |
|
|
Dr. Joseph A. Crawford, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Audrey C. Rhee, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jennifer L. Bennett, MD |
|
|
Dr. Justin P. Isariyawongse, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David A. Levy, MD |
|
|
Dr. Maude Carmel, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Matthew J. Bream, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Adrienne Quirouet, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Zhina Sadeghi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Karin E. Westesson, MD |